Cigna beats quarterly profit expectations as COVID medical costs fall
By Leroy Leo
Feb 3 (Reuters) -Cigna Corp CI.N beat Wall Street estimates for quarterly profit on Friday, aided by a sharp fall in medical costs due to lower COVID-19-related hospitalizations.
Health insurers have largely managed to keep medical costs in check during the fourth quarter amid a so-called "tripledemic" of an early flu season coinciding with COVID and respiratory syncytial virus cases.
Cigna's quarterly medical care ratio, or its spending on claims as a percentage of premiums, declined to 84.0% from 87.0%, and was better than the analysts' average estimate of 84.28%, according to Refinitiv data.
However, the company's annual profit forecast of at least $24.60 per share was marginally below expectations of $24.84 per share.
The insurer forecast medical care ratio of 81.5% to 82.5% for 2023, compared with Wall Street estimate of 81.9%.
The company, which served 18 million people in 2022 through its commercial and government-supported plans, expects to add at least 1.2 million customers this year.
Cigna's Evernorth unit, which operates its pharmacy benefit management business that negotiates between drugmaker and insurers, generated revenue of $36.19 billion, 3% higher than the previous year.
Excluding one-off items, the company reported a profit of $4.96 per share in the fourth quarter, beating analysts' average estimate by 10 cents.
Reporting by Leroy Leo in Bengaluru
Editing by Vinay Dwivedi
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
